Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21477426 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Olopatadine Hydrochloride Nasal Spray 0.6%;   Drug: Vehicle

Indicates status has not been verified in more than two years